ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Hyloris Pharmaceuticals Sa

Hyloris Pharmaceuticals Sa (0AB6)

0.00
0.00
( 0.00% )

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
28,000,000
Dividend Yield
-
PE Ratio
-9.69
Earnings Per Share (EPS)
-0.55
Revenue
4.21M
Net Profit
-15.38M

About Hyloris Pharmaceuticals Sa

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Liege, Liege, Bel
Founded
-
Hyloris Pharmaceuticals Sa is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0AB6. The last closing price for Hyloris Pharmaceuticals was -. Over the last year, Hyloris Pharmaceuticals shares have traded in a share price range of 0.00 € to 0.00 €.

Hyloris Pharmaceuticals currently has 28,000,000 shares outstanding. Hyloris Pharmaceuticals has a price to earnings ratio (PE ratio) of -9.69.

0AB6 Latest News

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Le total des produits et autres revenus atteint 4,4...

Hyloris Reports Full Year Results for 2023 & Provides Business Outlook

Hyloris Reports Full Year Results for 2023 & Provides Business Outlook Hyloris Reports Full Year Results for 2023 & Provides Business Outlook Total revenue and other income amounted to...

Communication at the request of the FSMA on the transactions with Qliniq

Communication at the request of the FSMA on the transactions with Qliniq Communication at the request of the FSMA on the transactions with Qliniq Revision of 2022 and half-year of 2023 (HY 2023...

Communiqué à la requête de la FSMA sur les transactions avec QliniQ

Communiqué à la requête de la FSMA sur les transactions avec QliniQ Communiqué à la requête de la FSMA sur les transactions avec QliniQ Retraitement des états financiers de 2022 et de juin 2023...

Hyloris Annonce ses Résultats Financiers Annuels le 14 mars 2024

Hyloris Annonce ses Résultats Financiers Annuels le 14 mars 2024 Liège, Belgique – le 8 mars 2024, 07:00 heures CET - Information non réglementée - Hyloris Pharmaceuticals SA (Euronext Bruxelles :...

Hyloris to Report 2023 Full-Year Results on 14 March 2024

Hyloris to Report 2023 Full-Year Results on 14 March 2024 Liège, Belgium – 08 February 2024, 07:00 AM CET – Non-regulated information – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a...

Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada

Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada...

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Maxigesic® IV, a Potent Non-opioid...

Hyloris Enrolls First Patient in Phase 3 Clinical Trial for its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental Procedures

Hyloris Enrolls First Patient in Phase 3 Clinical Trial for its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental Procedures Innovative oral care solution aims to benefit...

Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires

Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires Une...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

0AB6 - Frequently Asked Questions (FAQ)

What is the current Hyloris Pharmaceuticals share price?
The current share price of Hyloris Pharmaceuticals is 0.00 €
How many Hyloris Pharmaceuticals shares are in issue?
Hyloris Pharmaceuticals has 28,000,000 shares in issue
What is the 1 year trading range for Hyloris Pharmaceuticals share price?
Hyloris Pharmaceuticals has traded in the range of 0.00 € to 0.00 € during the past year
What is the PE ratio of Hyloris Pharmaceuticals?
The price to earnings ratio of Hyloris Pharmaceuticals is -9.69
What is the cash to sales ratio of Hyloris Pharmaceuticals?
The cash to sales ratio of Hyloris Pharmaceuticals is 35.35
What is the reporting currency for Hyloris Pharmaceuticals?
Hyloris Pharmaceuticals reports financial results in EUR
What is the latest annual turnover for Hyloris Pharmaceuticals?
The latest annual turnover of Hyloris Pharmaceuticals is EUR 4.21M
What is the latest annual profit for Hyloris Pharmaceuticals?
The latest annual profit of Hyloris Pharmaceuticals is EUR -15.38M
What is the registered address of Hyloris Pharmaceuticals?
The registered address for Hyloris Pharmaceuticals is BOULEVARD PATIENCE ET BEAUJONC, LIEGE, LIEGE, 4000
What is the Hyloris Pharmaceuticals website address?
The website address for Hyloris Pharmaceuticals is www.hyloris.com
Which industry sector does Hyloris Pharmaceuticals operate in?
Hyloris Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GILDGuild Esports Plc
0.075p
(66.67%)
156.91M
MSMNMosman Oil And Gas Limited
0.039p
(56.00%)
2.18B
MODER8 Capital Investments Plc
2.15p
(43.33%)
6.43M
LENDSancus Lending Group Limited
0.60p
(33.33%)
2.2M
KMKKromek Group Plc
6.65p
(25.47%)
39.04M
FUMFutura Medical Plc
17.00p
(-45.16%)
8.41M
RCDORicardo Plc
264.00p
(-25.00%)
4.21M
PEGPetards Group Plc
6.50p
(-18.75%)
706.63k
SCGLSealand Capital Galaxy Limited
6.50p
(-14.47%)
4.82M
SIVSivota Plc
3.00p
(-14.29%)
7.5k
MSMNMosman Oil And Gas Limited
0.039p
(56.00%)
2.18B
DKEDukemount Capital Plc
0.054p
(20.00%)
1.36B
EMEEmpyrean Energy Plc
0.1225p
(11.36%)
865.83M
TRPTower Resources Plc
0.0295p
(3.51%)
468.23M
NTVONativo Resources Plc
0.0019p
(0.00%)
309.74M

Discussion

View Full Feed
H2004 H2004 46 seconds ago
$QMMM Major improvement on volume. That being said, I am locked and loaded..."Ready on the left, ready on the right?" Awaiting the the "commence firing" command. Fond memories of Basic Training...Cheers!!!
QMMM
i_like_bb_stock i_like_bb_stock 1 minute ago
DUO is like a pot getting ready to boil over here time for its quarterly double
MasterBlastr MasterBlastr 1 minute ago
It took me 3 years before I got a badge, but I didn't play all that much.
SPARK SPARK 1 minute ago
Gotta get that RS done first~
PTOP
i_like_bb_stock i_like_bb_stock 1 minute ago
DUO is like a pot getting ready to boil over here time for its quarterly double
reinhart 13 reinhart 13 1 minute ago
Exactly, this has been way undervalued for too long🤔
AZRH
ProfitChaser ProfitChaser 2 minutes ago
Looks like the RS is working put on this one
Bubae Bubae 2 minutes ago
The Q3 filing should provide something of a reality check. They needed to borrow $562,500 which included the $250K that the Leons had to loan to get through Q3 2024. Now the reverse split to support what will be the newly filed regulation A offering that Shawn Leon has also been talking about. Go ba
GRST
rich2 rich2 2 minutes ago
Gitreal and fellow bashers, I apologize for

calling you folks retards. Your constant lying and twisting the truth caused me and possibly a few others to cross a line I normally don't cross
I like to report my opinion with facts that I know, you have constantly stated in many of
NBRI
manibiotech manibiotech 2 minutes ago
They "voluntarily" went to OTC for a reason  
NWBO
sissyjane1 sissyjane1 2 minutes ago
Yes, it would be nice to fully understand what the heck is going on with all of this, seems like alot of loose ends with no one trying to tie everything together for a objective outcome , seems like the start up and progression was not planned very well. Seems like no one has a planned working relat
MONI
Flyfishing Flyfishing 2 minutes ago
Take a look at RMXI, Bid 3.50 - Ask 5.00 - Vol 450
RMXI
DiamondHealer95 DiamondHealer95 2 minutes ago
AMEN

I just replied to someone's post saying the same thing, a bit more detailed, a bit nastier.
KBLB
learningcurve2020 learningcurve2020 3 minutes ago
Technically she didn’t sell Cognate, instead she sold her % then later they sold it. But I’m sure that was all factored into her departure.
NWBO
nowwhat2 nowwhat2 3 minutes ago
Well YOU may not be a chart reader but MILLIONS of us are.......and MANY of us watch for the very same thing.....
A person's gotta be STUPID to not understand and use charts.

https://investorshub.advfn.com/uimage/uploads/2025/1/30/qlrhtGC00_!_30_1Y_8AM_BO_BARS.jpg
BTCUSD
westjtter westjtter 3 minutes ago
yup....I think PSS has a lot more in the hamper....2025 and 2026 are going to be very big for this stock! IMO
IBRX
DiamondHealer95 DiamondHealer95 3 minutes ago
Stockinvest.us also does this and it's all based on current factors.

They did this at this time so they can say the stock is over performing once they start sales, marketing, and advertising. This 24/7 article which is NOT going to help the company gain traction is there solely for t
KBLB
stealofadeal stealofadeal 3 minutes ago
$GEVI The company has been in California fighting the fire. I think some news with Mighty Fire Breaker may come soon.
GEVI
ace65 ace65 3 minutes ago
Looks ready here..bid double the ask size
TKMO
Investor082 Investor082 3 minutes ago
Doesn’t matter. They will try to dangle some carrots there as they always do and then minions will hype it. Nothing happens after that and they move on or it’s forgotten.

We have seen so many examples of that over the years. Remember that $3M financing? Multiple franchisees? Multiple
NWBO
Str8t-talk Str8t-talk 3 minutes ago
https://finance.yahoo.com/news/bion-supplies-organic-fertilizer-samples-142500504.html
BNET
jay_tee jay_tee 3 minutes ago
I've been here since 2017 dealing with Seamazz you idgit! Yep the pot calling the kettle black! Huh? Who's the real idgit here? I guess I am one also.LoL
RNVA
Tadaaa Tadaaa 4 minutes ago
Got to Love This point of view !!

https://www.crypto-news-flash.com/could-hederas-ai-push-hbar-to-1t/

HBARUSD
diggitydoodle diggitydoodle 4 minutes ago
One big thing...
the great CEO has never said in black and white that he will share any success from FOXO with the shareholders of this ticker.
Wishing, hoping, praying and predicting doesn't count.
RNVA!!$$??????????????????
FOXO RNVA